99mTc-3PRGD2

3PRGD2 radiopharmaceutical · Peking University Cancer Hospital & Institute

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 99mTc-3PRGD2, covering 2024-05-30 to 2024-05-30. Get the full timeline:

Most recent: Clinical Trial Update: Molecular Imaging of Gastric Cancer Metastatic Lymph Nodes with 99mTc-3PRGD2 Probe. [NA]